DOS47 Drug Candidates
Our most advanced Tumor Defence Breaker L-DOS47 is currently in clinical trials for pancreatic cancer
Clinical Trials
Clinical Trials
L-DOS47 monotherapy NSCLC (clinical trial # NCT02340208)
- Treatment Type:
- Treatment
- Phase:
- Phase 2, 100%
L-DOS47 combo PEM/CARBO NSCLC (clinical trial # NCT02309892)
- Treatment Type:
- Treatment
- Phase:
- Phase 1, 50%
L-DOS47 DOXO combo Pancreas (clinical trial # NCT04203641)
- Treatment Type:
- Treatment
- Phase:
- Phase 1, 50%
Research
Research
L-DOS47 combo Immune Checkpoints
- Treatment Type:
- Treatment
- Phase:
- Phase 2, 100%